Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma.

Kelly KM, Hodgson D, Appel B, Chen L, Cole PD, Horton T, Keller FG; COG Hodgkin Lymphoma Committee..

Pediatr Blood Cancer. 2013 Jun;60(6):972-8. doi: 10.1002/pbc.24423. Review.

PMID:
23255501
2.

[Treatment of Hodgkin lymphoma].

Tokunaga T, Nagai H.

Nihon Rinsho. 2014 Mar;72(3):538-41. Japanese.

PMID:
24724416
3.

Current approaches to the management of pediatric Hodgkin lymphoma.

Freed J, Kelly KM.

Paediatr Drugs. 2010 Apr 1;12(2):85-98. doi: 10.2165/11316170-000000000-00000. Review.

PMID:
20218745
4.

Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.

David KA, Mauro L, Evens AM.

Curr Treat Options Oncol. 2007 Oct;8(5):352-74. doi: 10.1007/s11864-007-0046-9. Review.

PMID:
18214690
5.

POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.

Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcon P, Chauvenet AR; Children's Oncology Group..

J Pediatr Hematol Oncol. 2006 Jun;28(6):362-8.

PMID:
16794504
6.

APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial.

Wimmer RS, Chauvenet AR, London WB, Villaluna D, de Alarcon PA, Schwartz CL.

Pediatr Blood Cancer. 2006 Mar;46(3):320-4.

PMID:
16200630
7.

Children's Oncology Group's 2013 blueprint for research: neuroblastoma.

Park JR, Bagatell R, London WB, Maris JM, Cohn SL, Mattay KK, Hogarty M; COG Neuroblastoma Committee..

Pediatr Blood Cancer. 2013 Jun;60(6):985-93. doi: 10.1002/pbc.24433. Review. Erratum in: Pediatr Blood Cancer. 2014 May;61(5):958. Mattay, Katherine M [corrected to Mattay, Katherine K].

PMID:
23255319
8.

Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphoma.

Bollard CM, Lim MS, Gross TG; COG Non-Hodgkin Lymphoma Committee..

Pediatr Blood Cancer. 2013 Jun;60(6):979-84. doi: 10.1002/pbc.24416. Review.

9.

Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma.

Schot BW, Zijlstra JM, Sluiter WJ, van Imhoff GW, Pruim J, Vaalburg W, Vellenga E.

Blood. 2007 Jan 15;109(2):486-91.

10.

Treatment of newly diagnosed advanced stage Hodgkin lymphoma.

Uhm J, Kuruvilla J.

Blood Rev. 2012 Jul;26(4):167-74. doi: 10.1016/j.blre.2012.04.001. Review.

PMID:
22542250
11.

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.

Tubiana M, Henry-Amar M, Carde P, Burgers JM, Hayat M, Van der Schueren E, Noordijk EM, Tanguy A, Meerwaldt JH, Thomas J, et al.

Blood. 1989 Jan;73(1):47-56.

12.

Prognostic factors in Hodgkin lymphoma.

Josting A.

Expert Rev Hematol. 2010 Oct;3(5):583-92. doi: 10.1586/ehm.10.50. Review.

PMID:
21083475
13.
14.

The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial.

Stiff PJ, Unger JM, Forman SJ, McCall AR, LeBlanc M, Nademanee AP, Bolwell BJ, Fisher RI; Southwest Oncology Group..

Biol Blood Marrow Transplant. 2003 Aug;9(8):529-39.

15.

Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group.

Josting A, Rueffer U, Franklin J, Sieber M, Diehl V, Engert A.

Blood. 2000 Aug 15;96(4):1280-6.

16.

The intergroup Hodgkin's disease in children. A study of stages I and II.

Gehan EA, Sullivan MP, Fuller LM, Johnston J, Kennedy P, Fryer C, Gilchrist GS, Hays DM, Hanson W, Heller R, et al.

Cancer. 1990 Mar 15;65(6):1429-37.

17.

[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].

Niu Y, Shi YK, He XH, Feng FY, Zhou LQ, Gu DZ.

Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):630-4. Chinese.

PMID:
19102946
18.

Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas.

Hawkins DS, Spunt SL, Skapek SX; COG Soft Tissue Sarcoma Committee..

Pediatr Blood Cancer. 2013 Jun;60(6):1001-8. doi: 10.1002/pbc.24435. Review.

19.

[Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study].

Kochbati L, Fdhila F, Belaid I, Rifi H, Barsaoui S, Ben Romdhane N, Bel Hadj Ali Z, Mezlini A, Oubich F, Maalej M.

Cancer Radiother. 2012 Oct;16(7):627-32. doi: 10.1016/j.canrad.2012.09.002. French.

PMID:
23084987
20.

Management of advanced stage Hodgkin lymphoma.

Advani R, Ai WZ, Horning SJ.

J Natl Compr Canc Netw. 2006 Mar;4(3):241-7. Review.

PMID:
16507271
Items per page

Supplemental Content

Support Center